[go: up one dir, main page]

HUT45897A - Process for production of medicines with big acid-fixing capacity, prolonged in time effect, increased bioutilty, neutralizing gastric acid - Google Patents

Process for production of medicines with big acid-fixing capacity, prolonged in time effect, increased bioutilty, neutralizing gastric acid

Info

Publication number
HUT45897A
HUT45897A HU264386A HU264386A HUT45897A HU T45897 A HUT45897 A HU T45897A HU 264386 A HU264386 A HU 264386A HU 264386 A HU264386 A HU 264386A HU T45897 A HUT45897 A HU T45897A
Authority
HU
Hungary
Prior art keywords
acid
bioutilty
medicines
prolonged
production
Prior art date
Application number
HU264386A
Other languages
Hungarian (hu)
Other versions
HU196711B (en
Inventor
Istvan Racz
Janos Plachy
Peter Szentmiklosi
Original Assignee
Istvan Racz
Janos Plachy
Peter Szentmiklosi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istvan Racz, Janos Plachy, Peter Szentmiklosi filed Critical Istvan Racz
Priority to HU264386A priority Critical patent/HU196711B/en
Priority to AU75481/87A priority patent/AU604721B2/en
Priority to DE19873790355 priority patent/DE3790355T/en
Priority to JP62503723A priority patent/JPS63503541A/en
Priority to DE3790355A priority patent/DE3790355C2/en
Priority to US07/165,102 priority patent/US4921707A/en
Priority to GB8804228A priority patent/GB2201594B/en
Priority to CH609/88A priority patent/CH674148A5/de
Priority to PCT/HU1987/000026 priority patent/WO1988000051A1/en
Priority to BE8701041A priority patent/BE1000496A7/en
Publication of HUT45897A publication Critical patent/HUT45897A/en
Publication of HU196711B publication Critical patent/HU196711B/en
Priority to US07/420,280 priority patent/US5087447A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU264386A 1986-06-24 1986-06-24 Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability HU196711B (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
HU264386A HU196711B (en) 1986-06-24 1986-06-24 Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability
US07/165,102 US4921707A (en) 1986-06-24 1987-06-24 Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability
DE19873790355 DE3790355T (en) 1986-06-24 1987-06-24 METHOD FOR THE PRODUCTION OF LIQUID ACID-NEUTRALIZING PHARMACEUTICAL PREPARATIONS WITH LARGE ACID-BINDING CAPACITY, DELAYED EFFECTIVENESS AND ENHANCED BIOAVAILABILITY
JP62503723A JPS63503541A (en) 1986-06-24 1987-06-24 Method for producing pharmaceutical formulations with high gastric acid binding capacity, delayed effect and high bioavailability
DE3790355A DE3790355C2 (en) 1986-06-24 1987-06-24 Prodn. of preparations of high gastric acid binding capacity
AU75481/87A AU604721B2 (en) 1986-06-24 1987-06-24 Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability
GB8804228A GB2201594B (en) 1986-06-24 1987-06-24 Production of acid binding pharmaceutical preparations
CH609/88A CH674148A5 (en) 1986-06-24 1987-06-24
PCT/HU1987/000026 WO1988000051A1 (en) 1986-06-24 1987-06-24 Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability
BE8701041A BE1000496A7 (en) 1986-06-24 1987-09-16 Method for pharmaceutical preparations with high production capacity of fixing the gastric acid, and pursuing an effect late with increased bioavailability.
US07/420,280 US5087447A (en) 1986-06-24 1989-10-12 Pharmaceutical preparations of high gastric acid binding capacity, delayed effect and of increased bioavailability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU264386A HU196711B (en) 1986-06-24 1986-06-24 Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability

Publications (2)

Publication Number Publication Date
HUT45897A true HUT45897A (en) 1988-09-28
HU196711B HU196711B (en) 1989-01-30

Family

ID=10960419

Family Applications (1)

Application Number Title Priority Date Filing Date
HU264386A HU196711B (en) 1986-06-24 1986-06-24 Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability

Country Status (4)

Country Link
JP (1) JPS63503541A (en)
AU (1) AU604721B2 (en)
DE (2) DE3790355T (en)
HU (1) HU196711B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010051226A1 (en) 2010-11-12 2012-05-31 Dental Care Innovation Gmbh Rinse-off tray with abrasive components
AU2018214552B2 (en) 2017-02-02 2021-12-23 Water Pik, Inc. Tablet comprising abrasive for dental cleaning
CN110780063A (en) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 Expiratory ammonia detection method and device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
AU5526173A (en) * 1972-05-12 1974-11-07 Armour Pharma Resuspendable dried antacids resuspendable dried antacids
DE2246037B2 (en) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Orally applicable drug with delayed absorption in suspension form
DE2510663C3 (en) * 1975-03-12 1981-08-06 Dr. Madaus & Co, 5000 Köln Aluminum polyhydroxisulphate, process for its production and medicament containing it
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
CH621083A5 (en) * 1977-04-01 1981-01-15 Ludwig Striebig Board-cutting circular saw
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
JPS56158716A (en) * 1980-05-14 1981-12-07 Kyowa Chem Ind Co Ltd Antacid preparation
JPS58105914A (en) * 1981-12-17 1983-06-24 Lion Corp Antacid having sustained activity
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets

Also Published As

Publication number Publication date
HU196711B (en) 1989-01-30
JPS63503541A (en) 1988-12-22
AU604721B2 (en) 1991-01-03
AU7548187A (en) 1988-01-29
DE3790355C2 (en) 1998-08-20
DE3790355T (en) 1988-06-23

Similar Documents

Publication Publication Date Title
EP0466279A3 (en) Novel random copolymer, and process for production thereof
EP0273708A3 (en) Process for production of eicosapentaenoic acid
EP0252716A3 (en) Process for production of bishomo- gamma-linolenic acid and eicosapentaenoic acid
GB2187744B (en) Process for producing 2, 6-naphthalenedicarboxylic acid
DE3661732D1 (en) Process for producing 4-biphenylylacetic acid
SG99494G (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it
HUT41774A (en) Process for producing thiazolidine-carboxylic acid
AR244674A1 (en) Thiolactam-n-acetic acid derivatives, their production and use
EP0261589A3 (en) Polymaleic acid, process for preparing polymaleic acid and its use
EP0231842A3 (en) Process for the production of 6-aminocaproic acid
HU911136D0 (en) Process for producing 1-tertiary-alkyl-substituted naphtyridine- and quinoline-carbonic acid derivatives and intermediate products
YU141886A (en) Process for producing l-ascorbinic acid
HUT44476A (en) Process for production of carbonic acid
HUT40789A (en) Process for producing 2,3,4,9-tetrahydro-1h-carbazol-1-acetic acid
HUT46021A (en) Process for producing ceph-3-eme-4-carboxylic acid derivatives
GB2199036B (en) New furanuronic acid derivatives, process for their production and their use
DE3364927D1 (en) 2-oxo-1-azetidinesulfonic acid derivatives, process for production thereof, and use thereof
DE3665859D1 (en) Process for producing 2,6-naphthalenedicarboxylic acid
EP0230988A3 (en) Process for the production of esters of 6-aminocaproic acid
HUT45897A (en) Process for production of medicines with big acid-fixing capacity, prolonged in time effect, increased bioutilty, neutralizing gastric acid
DE3374695D1 (en) L-2-hydroxy-4-methylpentanoic acid dehydrogenase, process for its production and its use
HUT46023A (en) Process for producing purin-9-yl-alkoxy-methyl-phosphonic acid derivatives
ES2015100B3 (en) ACID PRODUCTION PROCESS 4,4'- DINITROSTILBENO 2,2'DISULFON
DE3564680D1 (en) Gamma-aminobutyric acid derivatives, process for production thereof, and use thereof as medicaments
HU906329D0 (en) Process for producing pyridyl-cyclopropane-carboxylic acid derivatives

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
MM4A Lapse of definitive patent protection due to non-payment of fees